Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Tags:
Medicare, drug pricing, Inflation Reduction Act, JNJ, Xarelto, Imbruvica, Stelara, Bristol Myers Squibb, Eliquis, Eli Lilly, Jardiance, Merck, Januvia, Amgen, Enbrel, AstraZeneca, Farxiga, Novo Nordisk, Fiasp, Novartis, Entresto
Lilly demands doctors stop selling copycat weight-loss drugs
Reuters
Thu, 08/15/24 - 11:50 am
Tags:
Eli Lilly, drug counterfeiting, Zepbound, weight loss
Eli Lilly unwraps $700M nucleic acid R&D center in Boston Seaport, opens doors to biotechs
Fierce Biotech
Tue, 08/13/24 - 11:49 am
Tags:
Eli Lilly, Boston, R&D, DNA, RNA
Weight-loss drugs like Wegovy may help stave off some cancers
NPR
Mon, 08/12/24 - 11:28 am
Tags:
cancer, GLP-1 agonist, Wegovy, Zepbound, Novo Nordisk, Eli Lilly
Pharma execs react to final drug price negotiations with Medicare
Pharma Voice
Fri, 08/9/24 - 11:21 am
Tags:
Medicare, drug pricing, Inflation Reduction Act, Bristol Myers Squibb, Eli Lilly, JNJ, Bayer, Merck, AstraZeneca, Novartis, Amgen, AbbVie, Novo Nordisk
Lilly's tau drug for Alzheimer's flunks phase 2 test
Pharmaphorum
Fri, 08/9/24 - 11:18 am
Tags:
Eli Lilly, Alzheimer's disease, clinical trials, LY3372689
Lilly boosts outlook on rising Zepbound revenue
BioPharma Dive
Thu, 08/8/24 - 11:19 am
Tags:
Eli Lilly, earnings, Zepbound
Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half
Pharma Voice
Thu, 08/8/24 - 11:07 am
Tags:
Big Pharma, JNJ, AbbVie, Pfizer, Roche, Eli Lilly, Novo Nordisk, Merck
FDA says all doses of Lilly's weight-loss and diabetes drug are now available
Reuters
Sun, 08/4/24 - 06:44 pm
Tags:
Eli Lilly, FDA, Zepbound, Mounjaro, drug shortages
Lilly CEO says weight-loss drug shortage to end 'very soon', Bloomberg News reports
Reuters
Thu, 08/1/24 - 11:13 pm
Tags:
Eli Lilly, weight loss, Zepbound, drug shortages
Lilly says weight loss drug cuts heart failure risk by 38% in trial
Reuters
Thu, 08/1/24 - 11:08 am
Tags:
Eli Lilly, Zepbound, heart failure
Inside Eli Lilly’s multi-year Team USA partnership
Medical Marketing and Media
Wed, 07/24/24 - 11:51 am
Tags:
Eli Lilly, Olympics, branding, pharma marketing
Innovent’s Lilly-Partnered Type 2 Diabetes Drug Aces Phase III in China, Inches Closer to Approval
BioSpace
Mon, 07/22/24 - 06:50 pm
Tags:
Innovent Biologics, mazdutide, obesity, China, Eli Lilly
NC Medicaid to cover weight-loss drugs like Wegovy, after access cut for state workers
Yahoo/Raleigh News & Observer
Mon, 07/22/24 - 06:48 pm
Tags:
Novo Nordisk, Eli Lilly, obesity, Wegovy, Zepbound, North Carolina, Medicaid
Morphic kept it simple in M&A maneuvers, staying focused on Lilly to reel in $3.2B buyout
Fierce Biotech
Fri, 07/19/24 - 11:54 am
Tags:
Morphic, Eli Lilly, M&A
Eli Lilly's weight loss drug tirzepatide gets approval in China
Reuters
Fri, 07/19/24 - 11:45 am
Tags:
Eli Lilly, tirzepatide, China
A new biotech tackling IBD joins a race against Lilly and Gilead for a promising pill
Pharma Voice
Thu, 07/18/24 - 11:12 am
Tags:
Ensho Therapeutics, IBD, Gilead Sciences, Eli Lilly
As GLP-1 sales surge, insulin users fear Novo Nordisk and Eli Lilly will move on without them
Stat
Wed, 07/17/24 - 11:39 am
Tags:
Novo Nordisk, Eli Lilly, diabetes, insulin, patients
Will Eli Lilly overtake Novo Nordisk in weight-loss drug race?  
BioSpace
Tue, 07/16/24 - 12:11 pm
Tags:
Eli Lilly, Novo Nordisk, Wegovy, Zepbound, weight loss
Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.
Motley Fool
Mon, 07/15/24 - 09:53 am
Tags:
Eli Lilly, Kisunla, FDA, Alzheimer's disease`

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.